CytomX Therapeutics, Inc. CTMX

2.70 (0.05) (1.82%) as of 25 Sep
Market cap
$599.2M
P/E
0.0×
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.71 0.00
P/S ratio 25.80 11.29 10.57 6.55 3.01 7.44 1.99 1.23 0.63 7.71
P/FCF ratio 0.00 4.79 0.00 0.00 102.46 0.00 0.00 0.00 0.00 0.00
P/Operating CF 200.45 36.76 (21.89) (12.78) (17.34) (8.90) (75.98) (5.68) (4.37) (25.28)
P/B ratio 4.95 11.57 4.81 7.37 6.07 0.00 0.00 0.00 0.00 5.93
EV/Sales 13.70 6.07 3.24 1.45 (0.11) (0.64) (1.57) (0.45) (0.07) 5.97
EV/EBITDA 0.00 0.00 0.00 0.00 0.23 0.21 0.85 3.85 0.00 0.00
EV/FCF (49.60) 2.57 (2.43) (0.58) (3.62) 0.20 0.74 0.79 0.10 (6.00)
Current Ratio 5.26 6.36 4.55 3.54 3.21 3.98 1.55 1.17 1.25 3.09
Net Debt/EBITDA 3.24 8.46 5.61 2.65 6.76 2.67 1.92 14.49 (4.69) 5.91
Debt/Equity 0.00 0.00 0.00 0.06 0.06 (7.88) (0.05) (0.10) 0.00 0.00
ROE (57.59%) (58.09%) (84.28%) (112.35%) (65.17%) (469.64%) 230.41% 0.85% (133.06%) (41.34%)
ROA (29.72%) (14.44%) (19.80%) (25.61%) (9.40%) (33.20%) (33.09%) (0.25%) 19.77% (14.97%)
ROIC 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets (37.57%) (12.99%) (23.87%) (45.42%) (14.30%) (48.61%) (110.89%) (1.84%) 132.79% (20.66%)
Average Days of Receivables 56.12 51.67 0.60 0.08 2.90 7.73 247.07 12.38 8.20 9.64
Earnings Yield (15.13%) (5.42%) (13.25%) (27.20%) (10.69%) (42.01%) (75.82%) (1.18%) 36.89% (0.97%)
Free Cash Flow Yield (1.07%) 20.87% (12.61%) (38.22%) 0.98% (43.43%) (106.32%) (45.60%) (99.50%) (12.90%)
Free Cash Flow per Share (0.11) 4.54 (1.90) (3.18) 0.06 (1.88) (1.71) (0.77) (1.02) (0.55)
Book value per Share 2.17 1.88 3.14 1.13 1.08 (0.01) (1.30) (0.64) (0.01) 0.72
Free Cash Flow (4.16) 168.81 (79.31) (143.98) 2.95 (120.64) (112.53) (56.87) (86.54) (75.81)
EV/EBIT 0.00 0.00 0.00 0.00 0.22 0.21 0.83 6.97 0.00 0.00
Other line items

Show all line items

Columns are period end dates